D. MITCHELL KELLER - 15 Aug 2023 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Issuer symbol
XTNT
Transactions as of
15 Aug 2023
Net transactions value
$0
Form type
4
Filing time
17 Aug 2023, 16:32:50 UTC
Previous filing
15 Jun 2023
Next filing
19 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Award $0 +145,180 +317% $0.000000 190,962 15 Aug 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XTNT Stock Option (right to buy) Award $0 +28,230 $0.000000 28,230 15 Aug 2023 Common Stock 28,230 $1.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest and become issuable on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.
F2 Includes 145,180 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 45,782 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, all conditioned upon the Reporting Person remaining a director of Xtant through the vesting dates.
F3 This option vests on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.